Sharp Therapeutics Corp.
Research Sharp Therapeutics Corp. (SHRX) on Bullrun: market cap CAD 30.08M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerSHRX
- ExchangeV
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyCAD
- Market capCAD 30.08M
- Financial periodQ4 2025
- Net income-CAD 2.39M
- Free cash flow-CAD 975.60K
Valuation Snapshot
latest market cap is CAD 30.08M.
About Sharp Therapeutics Corp.
Sharp Therapeutics Corp., a preclinical-stage drug discovery company, develops therapeutics for genetic diseases. The company engages in the development of the CoreX, a suite of biology technologies that allows the creation of sensitive assays mimicking the genetic disease state, enabling discovery of compounds that correct the mutational defect; AlloChem, a compound library which binds proteins allosterically;
Frequently asked questions
What is Sharp Therapeutics Corp.'s market cap?
Sharp Therapeutics Corp.'s market capitalization is CAD 30.08M.
What does Sharp Therapeutics Corp. do?
Sharp Therapeutics Corp., a preclinical-stage drug discovery company, develops therapeutics for genetic diseases. The company engages in the development of the CoreX, a suite of biology technologies that allows the creation of sensitive assays mimicking the genetic disease state, enabling discovery...